Tsuyoshi Onoe

Plain English
This study focused on a 17-month-old boy with a milder form of Kawasaki Disease (KD) that initially did not show clear symptoms, which made it challenging to diagnose. On the 18th day of his illness, doctors found that he had developed problems in his coronary arteries, which led to treatment with IVIG (a medication to reduce inflammation). The research shows that regular heart imaging can catch these issues early, helping to treat the child effectively and prevent further complications. Who this helps: Patients with Kawasaki Disease and their doctors.

Plain English
This study looked at how effective and safe the drug nivolumab is for patients with hard-to-treat recurrent or metastatic salivary gland cancer. Out of 24 patients, only 2 showed improvement in their cancer (an 8.3% success rate), and 70.8% saw their condition worsen within 12 weeks. Although nivolumab didn't show strong results overall, it might still be helpful for a specific type of this cancer, known as salivary duct carcinoma. Who this helps: This research helps doctors understand treatment options for patients with certain types of salivary gland cancer.

Plain English
This study looked at how effective particle therapy is in treating liver cancer, specifically hepatocellular carcinoma (HCC). It found that for patients with tumors larger than 4 cm, particle therapy significantly improved survival rates compared to other treatments. The median overall survival was 53.7 months, and the one-year survival rate for these patients was 81.1%, while for smaller tumors, the survival rate was similar to another treatment called SBRT. Who this helps: This benefits patients with large liver tumors and their healthcare providers by providing access to a more effective treatment option.

Plain English
This study looked at the long-term effects of a treatment strategy called neoadjuvant chemotherapy (NAC) for patients with HPV-positive throat cancer. Out of 41 patients treated, 61% had no remaining cancer in their tissues after chemotherapy, and 5 years later, 92.4% were still alive without disease progression. This approach helped many patients avoid additional radiation therapies and showed that they could recover their ability to eat normally without significant long-term side effects. Who this helps: This benefits patients with HPV-related throat cancer and their doctors by offering a treatment option that may reduce the need for more invasive procedures.

Plain English
This study looked at a new combination of markers in the blood, albumin and butyrylcholinesterase, to see how well they can predict recovery after surgery for liver cancer (hepatocellular carcinoma). Researchers analyzed data from 1,712 patients and found that those with higher levels of these markers had significantly better outcomes, with a much higher 5-year survival rate of over 90% compared to lower levels. This new biomarker, called ABC, is useful because it can be easily measured and gives important information about patient prognosis after liver cancer surgery. Who this helps: This benefits patients with liver cancer and their doctors by providing clearer survival and recurrence predictions after surgery.

Plain English
This study examined the effects of low doses of imatinib, a cancer medication, on an 82-year-old man with a rare type of cancer called gastrointestinal stromal tumor (GIST). The patient’s tumor, which measured over 9 cm, decreased in size after starting treatment; it shrank as observed in CT scans over several months. This finding is significant because patients with a specific genetic mutation in their tumor, known as KIT exon 11 W557_K558 deletion, may benefit from lower doses of imatinib, especially if they cannot tolerate higher doses. Who this helps: This helps patients with GIST who have the specific genetic mutation and struggle with high-dose treatment.

Plain English
This study looked at how abdominal aortic calcification affects outcomes in elderly patients (over 80 years old) who have liver cancer called hepatocellular carcinoma (HCC) and undergo liver surgery. Researchers found that patients with high levels of abdominal aortic calcification had a much higher chance of cancer returning after surgery and had poorer survival rates. Specifically, those in the high calcification group experienced more recurrences and had lower survival without cancer than those in the low calcification group. Who this helps: This information benefits elderly patients with liver cancer and their doctors by highlighting the importance of evaluating abdominal aortic calcification before surgery.

Plain English
This study examined how two blood markers, alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP), can help predict the outcomes of patients with liver cancer (hepatocellular carcinoma, HCC) after surgery. It found that patients with high levels of both markers had a notably poor survival rate of 52.8% over five years and a high chance of recurrence at 79.3%. In contrast, those with low levels of both markers had better outcomes, with a five-year survival rate of 71.5% and a recurrence rate of 55.7%. This research is important as it highlights how doctors can use these markers to better understand a patient's cancer prognosis and personalize treatment plans. Who this helps: Patients with liver cancer and their doctors.

Plain English
This study focused on a 48-year-old man with a rare heart tumor called primary cardiac synovial sarcoma, which had grown into the wall of his heart. Doctors performed emergency surgery to remove the tumor completely, and six months later, he showed no signs of the cancer returning. This matter because it emphasizes the need for early detection of heart tumors, which can be hard to diagnose but are treatable when caught in time. Who this helps: This helps patients with heart tumors and their doctors by highlighting early detection and successful treatment options.

Plain English
This study focused on a rare type of liver cancer called alpha-fetoprotein-producing intrahepatic cholangiocarcinoma. A 71-year-old man was found to have a 40-mm tumor that produced high levels of alpha-fetoprotein, leading doctors to initially suspect another kind of liver cancer. Despite surgery and starting chemotherapy, the man's condition worsened, and he passed away 13 months later, highlighting the importance of accurately diagnosing liver tumors to determine the right treatment, as different types require different approaches. Who this helps: This information benefits doctors and patients by improving cancer diagnosis and treatment options.

Plain English
The study looked at how older patients in Japan with advanced head and neck cancer receive chemoradiotherapy, based on responses from a survey. The findings showed that specific treatment approaches vary significantly, with around 60% of doctors favoring chemoradiotherapy for these patients. This is important because it helps identify standard practices and improve treatment options for older patients facing this aggressive cancer. Who this helps: This benefits older cancer patients and their doctors in deciding on treatment plans.

Plain English
A 77-year-old woman with advanced colon cancer underwent surgery and initially received chemotherapy, but her cancer returned. After starting treatment with a drug called pembrolizumab, her tumor continued to grow until she added radiation therapy, which shrank the tumor significantly and kept it from coming back for over a year. This combination of treatments was effective, indicating that using immune therapies alongside radiation can improve outcomes for patients with certain types of cancer. Who this helps: This helps patients with MLH1 gene-deficient colon cancer who may benefit from new treatment combinations.

Plain English
This study looked at patients who have advanced cancers in both the esophagus and head/neck at the same time. Researchers analyzed data from 42 patients who received either surgery or chemotherapy and radiation between 2007 and 2024. They found that while survival rates were similar across different treatment options, patients receiving radiation had significantly more side effects, such as swallowing difficulties and needing feeding tubes. Who this helps: This study provides important information for doctors deciding on treatment plans for patients with these types of cancer.

Plain English
This study looked at the FIB-3 index, a new test that helps predict liver damage and survival chances for older patients with liver cancer who undergo surgery. Researchers analyzed data from over 1,000 patients and found that the FIB-3 index was better than the older FIB-4 index at identifying serious liver damage in elderly patients. This is important because it helps doctors better assess the risk of cancer recurrence and overall survival after surgery, leading to more personalized treatment plans. Who this helps: This helps patients with liver cancer, especially older adults, and their doctors.

Plain English
This study examined how to best dose the cancer medication sunitinib for an 83-year-old man with gastrointestinal stromal tumors after his previous treatment failed. The patient started with a high dose of 50 mg but faced side effects like nausea, leading to a reduced dose of 25 mg, which ultimately helped manage the side effects effectively. The research indicates that using platelet counts to adjust sunitinib dosing can improve treatment for older patients facing similar challenges, achieving some tumor shrinkage without serious complications. Who this helps: This helps older cancer patients and doctors treating them to make safer treatment choices.

Plain English
This study focused on understanding what factors might lead to doctors switching patients from a minimally invasive liver surgery to a more invasive type, called open surgery. Out of 199 patients treated, 172 successfully had laparoscopic surgery, while 27 had to switch to open surgery. It was found that factors like having a previous liver surgery and being male increased the chances of conversion, which also resulted in longer surgery times, more blood loss, and longer hospital stays. Who this helps: This information can help doctors plan better and prepare patients for liver surgeries.

Plain English
This study looked at a specific type of surgery, called "bailout surgery," for patients with moderate to severe acute cholecystitis, a serious condition involving the gallbladder. Out of 547 patients, 129 needed this additional surgical approach, which showed that those undergoing laparoscopic bailout surgery lost less blood, had shorter surgery times, and experienced fewer complications compared to those who had to switch to open surgery. This is important because it suggests that laparoscopic bailout surgery can help manage difficult cases more safely, reducing the risk of major injuries during surgery. Who this helps: Patients with severe gallbladder issues who require surgical intervention.

Plain English
This study focused on diagnosing a genetic kidney disease called ADTKD-UMOD by measuring levels of a protein called uromodulin in blood and urine samples. It found that patients with ADTKD-UMOD had significantly lower average serum uromodulin levels (24.5 ng/ml) compared to those with other diseases, and a serum level below 56.4 ng/ml is a strong indicator of having ADTKD-UMOD. This finding matters because it provides a simpler, more reliable diagnostic method that can help identify the disease earlier, potentially improving patient management before serious kidney damage occurs. Who this helps: This benefits patients with hereditary kidney disease and their healthcare providers.

Plain English
This study focused on a 68-year-old man with a type of cancer called hilar cholangiocarcinoma. To prepare for surgery, doctors performed two procedures to increase the size of his liver's functional area, resulting in a 41.8% increase in usable liver volume before the operation. After successful surgery, the patient had a smooth recovery and has not shown any signs of cancer returning for four months. Who this helps: This research benefits patients with liver cancer by showing a successful approach to preparing for surgery.

Plain English
This study looked at the effectiveness and safety of proton beam therapy (PBT) for treating liver cancer (hepatocellular carcinoma). Out of 576 patients treated, about 83.8% survived for at least one year, and the average overall survival time was nearly 49 months. The results are important because they show that PBT offers good control of the cancer with a low risk of severe side effects, making it a promising option for patients. Who this helps: Patients with hepatocellular carcinoma and their doctors.

Plain English
Researchers studied the safety and effectiveness of a less invasive surgery called laparoscopic liver resection for older patients (80 years and older) with liver cancer. They found that patients who had laparoscopic surgery experienced significantly less bleeding and fewer heart and lung complications compared to those who had traditional open surgery. This is important because it shows that this surgical method can be safely used for very elderly patients, potentially leading to better recovery outcomes. Who this helps: This helps older patients with liver cancer and their doctors in making surgery decisions.

Plain English
This study looked at how different treatments for hepatitis C, specifically direct-acting antivirals (DAAs) and interferon (IFN), affected the chances of liver cancer coming back after surgery. Researchers tracked 593 patients and found that those who achieved a sustained virological response (SVR) before surgery had a higher survival rate—82.2% over five years, compared to 63.9% for those who did not reach SVR. Importantly, there was no difference in cancer recurrence or overall survival between patients treated with DAAs or interferon before surgery, even though liver function was worse in those who received DAAs at the time of their operations. Who this helps: This information is valuable for patients with hepatitis C and liver cancer, as well as their doctors, to understand treatment options before surgery.

Plain English
This study looked at how losing body fat after surgery affects survival rates in patients with pancreatic cancer. Researchers found that if patients lost 14% or more of their body fat within the first month after surgery, their chances of survival were poorer. Specifically, 46% of patients who had surgery saw this kind of fat loss, along with other factors like having cancer spread to lymph nodes which also negatively impacted their prognosis. Who this helps: This information helps doctors better understand risks for their patients with pancreatic cancer after surgery.

Plain English
This study looked at the outcomes of a specific type of surgery done on patients who had recurrent sino-nasal cancers after receiving proton beam therapy. Out of nine patients treated between 2002 and 2023, all surgeries were successful in preventing cancer from coming back, and there were no deaths during or immediately after surgery. However, 33% of the patients had some complications, mainly infections. Who this helps: This helps patients with sino-nasal cancers who may need further treatment after proton beam therapy.

Plain English
This study looked at a rare case of a 77-year-old woman who was found to have two different types of liver cancer at the same time: hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Doctors used imaging tests to diagnose the two tumors before surgery, and after successfully removing them, the patient received eight chemotherapy treatments and had no signs of cancer returning after one year. This is important because it shows how advanced imaging can help identify different types of liver cancer together and the benefit of chemotherapy after surgery. Who this helps: This helps patients with liver cancer and their doctors in making more informed treatment decisions.

Plain English
This study looked at how effective a lower dose of radiation therapy (40 Gy) is for treating myxoid liposarcoma, a type of cancer that can be sensitive to radiation. Researchers found that this lower dose led to a significant tumor size reduction of about 52% before surgery, with fewer complications compared to higher doses. They also noted that patients who couldn't have surgery still experienced a 55% reduction in tumor size, maintaining that shrinkage over more than four years of follow-up. Who this helps: This benefits patients with myxoid liposarcoma, especially those who are elderly or have other health issues.

Plain English
This study looked at a 46-year-old man with von Hippel-Lindau disease who had multiple tumors in his pancreas and kidneys. The patient underwent two surgeries to remove these tumors, including a total removal of his pancreas and parts of both kidneys. After the surgeries, he experienced liver cancer recurrence 22 months later but is still alive 41 months after the initial surgery. This is important because it shows that even in complicated cases with multiple cancers, surgical intervention can extend survival. Who this helps: This helps patients with von Hippel-Lindau disease and their doctors.

Plain English
This study looked at a new treatment approach combining paclitaxel and cetuximab for patients with recurrent or advanced head and neck cancer who had already been treated with standard therapies. The results showed that nearly 70% of patients (specifically 69.6%) responded positively to this treatment, with an average survival time of about 13.3 months. This research is important because it offers hope for better outcomes in a group of patients who currently have limited options. Who this helps: Patients with recurrent or metastatic head and neck cancer.

Plain English
This study examined how the amount of cisplatin (a chemotherapy drug) given to patients with advanced head and neck cancer relates to their muscle mass and the side effects they experience. Researchers found that patients with a higher relative dose of cisplatin compared to their muscle mass faced worse side effects; specifically, 26.9% of these patients had severe blood-related issues compared to 16.3% of those with a lower dose. This matters because it suggests that measuring muscle mass could help doctors better determine the safest and most effective dose of cisplatin for their patients. Who this helps: This helps patients undergoing treatment for head and neck cancer.

Plain English
Researchers studied how well machine learning (ML) can predict liver failure after surgery in patients with liver cancer. They evaluated 334 patients and found that an ML model called extreme gradient boosting achieved a high accuracy of 93.1% and outperformed traditional methods for prediction. This is important because better predictions can help doctors identify patients at risk for serious complications after liver surgery, potentially reducing mortality rates. Who this helps: This helps patients undergoing liver surgery and their doctors.

Plain English
This study looked at how patients with early-stage breast cancer in Japan feel about a new radiation therapy called ultra-hypofractionated (UHF) treatment, which is quicker than traditional methods. Out of 247 patients surveyed, 69% showed a good enthusiasm for UHF, rating it 6 or higher out of 10, with 45% giving it a perfect score. Most patients prioritized treatment effectiveness (89%) over cosmetic results (53%), highlighting the importance of efficient care. Who this helps: This helps patients with early-stage breast cancer.

Plain English
This study looked at patients with brain metastases who were treated with palliative whole-brain radiotherapy (WBRT) to relieve symptoms. Researchers found that the average survival time for these patients was about 4.1 months. They developed a scoring system that helps predict how long patients might live after treatment, with patients scoring 0-2 expected to live about 9 months, while those scoring 4-5 had a median survival of only 1.7 months. Who this helps: This research benefits doctors and healthcare providers in making better treatment decisions for patients with brain metastases.

Plain English
This study looked at a specific type of bile leakage that can happen after surgery for liver cancer. Researchers found that when bile leaked from a damaged area of the liver after surgery, traditional treatments didn’t work, so a surgical connection between the bile duct and the small intestine was created. This approach, called Roux-en-Y hepaticojejunostomy, helps preserve healthy liver tissue and avoid further complications, particularly in patients with liver cancer. Who this helps: This benefits patients who experience bile leakage after liver surgery, especially those with liver cancer.

Plain English
This study looked at a case of a man in Japan who died from an overdose of the drug pregabalin, which is used to treat pain, epilepsy, and anxiety. The autopsy found a fatal level of pregabalin in his blood (18.5 µg/mL), but it was not detected in routine screenings by the police, highlighting a gap in testing. This issue is important because it shows that as more people use pregabalin, there is a growing risk of overdose, and doctors need to be aware of this danger when prescribing it. Who this helps: This helps patients who are prescribed pregabalin and the doctors who treat them.

Plain English
This study looked at the role of a protein called TMPRSS4 in predicting outcomes for patients with biliary tract cancer (BTC) after surgery. Out of 85 patients, 54% had high levels of TMPRSS4, and those patients had worse survival rates, living an average of 25.3 months compared to others, and also had a higher chance of their cancer coming back. Understanding TMPRSS4's role could help doctors better assess which patients might need more aggressive treatment after surgery. Who this helps: This helps patients with biliary tract cancer and their doctors by providing insight into prognosis after surgery.

Plain English
This study looked at how well the liver immune status index (LISI) can predict outcomes for patients who had surgery for liver cancer (hepatocellular carcinoma). It analyzed data from 1,337 patients and found that LISI was better at predicting survival and recurrence of cancer after surgery compared to existing methods, especially for those with complications like blood vessel invasion. Using LISI alongside other factors improved accuracy in assessing patient risk and can help doctors tailor treatments better. Who this helps: This helps patients with liver cancer and their doctors.

Plain English
This study looked at how well two different surgical approaches work for patients with severe acute cholecystitis, a serious infection of the gallbladder. Researchers compared early surgery within 72 hours of symptoms starting to delayed surgery and found that while both approaches had similar outcomes, patients with certain conditions, like cardiovascular issues or those on blood thinners, benefited more from a procedure called cholecystostomy before the main surgery. Specifically, patients who had cholecystostomy experienced less bleeding and shorter hospital stays. Who this helps: This research is useful for patients with severe acute cholecystitis, particularly those with additional health concerns, as well as their doctors in deciding the best treatment plan.

Plain English
This study looked at insomnia, a common issue for cancer patients, and explored what factors contribute to it and how to treat it effectively. Researchers reviewed 75 studies on different types of cancers and found that insomnia can result from factors like age, mental health issues (such as depression or anxiety), physical symptoms (like pain or fatigue), and the effects of cancer treatments. Since there are few effective sleep medications available, it's important for healthcare providers to create a thorough plan for identifying and managing sleep problems in cancer patients. Who this helps: This helps patients dealing with insomnia related to cancer and their healthcare providers.

Plain English
Researchers studied how doctors decide if older patients with advanced head and neck cancer should receive a specific type of treatment called chemoradiotherapy (CRT) in Japan. They found that doctors generally agree on giving this treatment to patients aged 65-74 who are relatively healthy, but not to those over 75 or with poor kidney function. This matters because it helps clarify which older patients are likely to benefit from this aggressive treatment and sets the stage for better clinical guidelines in the future. Who this helps: This helps doctors make informed treatment decisions for older cancer patients.

Plain English
This study looked at a specialized surgery called retroperitoneoscopic resection for patients with colorectal cancer that has spread to lymph nodes in the para-aortic area. Out of 9 patients who underwent this procedure, the researchers found that while it involved more blood loss and took longer, it successfully removed more lymph nodes, which can lead to better outcomes for patients with extensive disease. This is important because improving surgery results can extend survival for these patients. Who this helps: This helps patients with advanced colorectal cancer and their doctors.

Plain English
The study focused on a 74-year-old man with colon cancer that had spread to his liver, resulting in 16 tumors up to 6.5 cm in size. After receiving chemotherapy, the tumors shrank enough to make surgery possible. The doctors then performed a two-stage surgical procedure to remove the cancer, and the patient is currently doing well without complications or signs of cancer returning. Who this helps: This helps patients with colorectal cancer and liver metastases by showing that aggressive treatment can lead to successful outcomes.

Plain English
This study looked at how well the Palliative Prognostic Index (PPI) can predict survival in patients with bleeding gastric cancer, specifically to figure out who should receive a certain type of radiation therapy. They found that patients with a PPI score of 2 or lower had a median survival of about 6.7 months, while those with scores above 4 had a median survival of just 1 month. This information is important because it helps doctors decide when to use single-fraction radiotherapy for patients who are likely to have a short time left to live. Who this helps: This research benefits patients with bleeding gastric cancer and their doctors by improving treatment decisions.

Plain English
This study looked at the outcomes for patients who had a second liver surgery after liver cancer came back following an initial surgery. Researchers found that 63.2% of these patients survived for five years after the second surgery, but only 23.7% remained free of cancer in that same time. Key factors impacting survival included having larger tumors, multiple tumors, and a specific health rating, with patients having two or more bad factors seeing their five-year survival drop to 30.6%. Who this helps: This information helps doctors make better decisions for patients with recurring liver cancer after surgery.

Plain English
This research looked at how multidisciplinary tumor boards (MTBs) can improve the treatment of head and neck cancer. The authors found that a well-organized MTB leads to better decision-making by discussing each patient's unique situation and creating a tailored treatment plan. They also highlighted that creating virtual MTBs can help connect different medical teams and ensure that all patients receive high-quality care, regardless of where they are treated. Who this helps: This helps patients with head and neck cancer and their healthcare teams.

Plain English
This study looked at a new method for removing liver tumors called the dual-wield parenchymal transection technique, which uses two specialized devices at the same time. Researchers tested this on 19 patients and found that 26.3% experienced significant blood loss during surgery, with an average blood loss of 545 mL. There were no deaths, and while 21.1% had major complications, the method was deemed safe and feasible for liver surgery, providing a promising option for future treatments. Who this helps: This helps patients with liver tumors by potentially offering a more effective surgical technique.

Plain English
This study looked at the treatment of an 86-year-old woman with advanced esophageal cancer that couldn't be surgically removed. She was given a combination of two drugs, ipilimumab and nivolumab, which reduced the size of her tumors after two cycles of treatment. Although her cancer grew back after several months, this approach shows promise as an effective option for elderly patients who can't undergo standard chemotherapy. Who this helps: This helps elderly patients with advanced esophageal cancer.

Plain English
This study looked at a 74-year-old man with advanced liver cancer (hepatocellular carcinoma) who underwent surgery to remove two large tumors. Following surgery, the cancer returned in multiple places, but after more surgery and a year of chemotherapy with a drug called lenvatinib, there have been no signs of the cancer returning for 16 months. This is important because it shows that aggressive treatment, including surgery and chemotherapy, can be effective for certain patients with advanced liver cancer. Who this helps: This helps patients with advanced liver cancer and their doctors by providing insights into potential treatment options.